Fig. 2: Prognosis of patients is negatively correlated with BRD4 expression. | Cell Death & Disease

Fig. 2: Prognosis of patients is negatively correlated with BRD4 expression.

From: Ferritinophagy is required for the induction of ferroptosis by the bromodomain protein BRD4 inhibitor (+)-JQ1 in cancer cells

Fig. 2

a–f Higher BRD4 expression was correlated with both poorer overall survival (OS) and poorer disease-free survival (DFS) in BRCA (a, b) (High/Low: N = 38), LUAD (c, d) (High/Low: N = 32), and LGG (e, f) (High/Low: N = 257) patients in The Cancer Genome Atlas (TCGA) database. g–j Higher BRD4 expression was correlated with poorer DFS in BLCA (g) patients (High/Low: N = 201) and with poorer OS in KIRP (h) (High/Low: N = 141), SKCM (i) (High/Low: N = 229), and MESO (j) (High/Low: N = 41) patients in the TCGA database. k, l Higher BRD4 expression was correlated with both poorer OS (k) and poorer DFS (l) in pan-cancer patients (High: N = 4750, Low: N = 4749) in the TCGA database

Back to article page